These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24642958)

  • 1. A family with a novel termination mutation in hepatic nuclear factor 1α in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy.
    Demol S; Lebenthal Y; Bar-Meisels M; Phillip M; Gat-Yablonski G; Gozlan Y
    Horm Res Paediatr; 2014; 81(4):280-4. PubMed ID: 24642958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturity onset diabetes of the young: Seek and you will find.
    Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
    Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
    Pearson ER; Liddell WG; Shepherd M; Corrall RJ; Hattersley AT
    Diabet Med; 2000 Jul; 17(7):543-5. PubMed ID: 10972586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
    Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
    Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
    Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM
    Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular characterization of maturity onset-diabetes of the young caused by hepatocyte nuclear factor-4 alpha mutation: red flags for prediction of the diagnosis.
    Mohamed S; Elkholy S; El-Meleagy E; Abu-Amero K; Hellani AM
    Ann Saudi Med; 2014; 34(3):217-21. PubMed ID: 25266181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
    Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment switch from multiple daily insulin injections to sulphonylureas in an African young adult diagnosed with HNF1A MODY: a case report.
    Katte JC; Dehayem MY; Colclough K; Sobngwi E
    J Med Case Rep; 2024 Oct; 18(1):506. PubMed ID: 39420387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturity onset diabetes of the young: identification and diagnosis.
    McDonald TJ; Ellard S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood obesity complicating the differential diagnosis of maturity-onset diabetes of the young and type 2 diabetes.
    Weintrob N; Stern E; Klipper-Aurbach Y; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2008 Feb; 9(1):60-4. PubMed ID: 18036134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing.
    Miedzybrodzka Z; Hattersley AT; Ellard S; Pearson D; de Silva D; Harvey R; Haites N
    Eur J Hum Genet; 1999 Sep; 7(6):729-32. PubMed ID: 10482964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nonsense mutation of the HNF1α in maturity-onset diabetes of the young type 3 in Asian population.
    Fang C; Huang J; Huang Y; Chen L; Chen X; Hu J
    Diabetes Res Clin Pract; 2015 Aug; 109(2):e5-7. PubMed ID: 26050565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High sensitivity to sulphonylurea treatment in 2 patients with maturity-onset diabetes of the young type 3].
    Bosselaar M; Hattersley AT; Tack CJ
    Ned Tijdschr Geneeskd; 2002 Apr; 146(15):726-9. PubMed ID: 11980375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic causes and treatment of neonatal diabetes and early childhood diabetes.
    Barbetti F; D'Annunzio G
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):575-591. PubMed ID: 30086875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.